September 25, 2017 - September 28, 2017
HCV - International Symposium on Hepatitis C Virus and Related Viruses
Hyannis, MA, United States
September 25, 2017 - September 29, 2017
Citi Pan-Euro Healthcare Trip
The Trout Group to Host Trout Talk With John Bell, PhD of University of Ottawa and Director of the Canadian Oncolytic Virus Consortium
June 13, 2016
NEW YORK, NY -- (Marketwired) -- 06/13/16 -- The Trout Group, the leading global investor relations and strategic advisory firm servicing the life sciences industry, today announced an upcoming Trout Talk key opinion leader (KOL) discussion featuring John Bell, PhD, Professor of Microbiology and Immunology at University of Ottawa. Dr. John Bell will talk about "Oncolytic viruses: Biological machines for cancer therapy". The Trout Talk will be webcast live on June 17th at 12pm ET and can be accessed at trouttalk.troutgroup.com.
Trout Talks is an ongoing series featuring conversations with prominent and up-and-coming researchers who are driving scientific innovation forward.
Dr. Bell is an expert in the field of oncolytic viruses, a cancer immunotherapy approach that has recently seen its first FDA approval with drug T-VEC.
"Our research program is directed towards the identification and characterization of novel cancer killing therapeutic viruses that selectively infect and kill cancer cells, while leaving healthy cells and tissues unharmed. Not only do we discover and design new therapeutic viruses, but we also manufacture them for eventual clinical translation and commercialization."
Dr. Bell's current research is focused on Rhabdovirus and Orthopoxviruses.
The Trout Talk, moderated by Trout Group scientific advisor Neil Canavan, will consist of a 1 hour presentation by Dr. Bell followed by up to 30 minutes of Q&A. Webcast participants can send questions to firstname.lastname@example.org at any time before or during the event; submitted questions will be answered in the order received, and the asker's identity shall remain anonymous.
About The Trout Group:
The Trout Group is a global investor relations and strategic advisory firm. Since 1996, Trout has been a leading strategic partner to the life sciences industry, connecting companies, the capital markets and innovations in the sector. Trout's unique suite of services at the intersection of scientific advances and a network of institutional relationships creates long term value for stakeholders.
For general inquiries please contact:
Source: The Trout Group LLC